Key result
STEMI care without on-site surgery shows no difference in 30-day mortality versus on-site surgery.
Why the study?
It is important to examine outcome differences between hospitals with and without on-site coronary artery bypass graft surgery using contemporary data to clarify previous conflicting findings.
Cohort (n=21,924)
Yes
Odds Ratio: 1.06 (95% CI 0.88–1.29)
Absolute Event Rate: 11.32% vs 10.86%
Association in registry data should not change STEMI site selection; leaves open need for randomized confirmation of long-term revascularization benefit.
BACKGROUND: Many studies have revealed no outcome differences among patients undergoing percutaneous coronary intervention (PCI) in hospitals with and without surgery on-site (SOS), but one earlier study found differences in target vessel PCI rates and in mortality for patients with acute myocardial infarction who did not undergo PCI. It is important to examine outcome differences between SOS and non-SOS hospitals with more contemporary data. METHODS AND RESULTS: A total of 21 924 propensity-matched patients who were discharged between January 1, 2013, and November 30, 2015, who were in the New York PCI registry and other hospital databases were used to compare outcomes in hospitals with and without SOS for all patients and for patients with and without ST-segment-elevation myocardial infarction (STEMI) undergoing PCI. Also, 30-day mortality was compared for patients with STEMI regardless of whether they underwent PCI. For all patients with PCI and patients without STEMI, there were no significant differences in in-hospital/30-day mortality, 2-year mortality, or 2-year repeat target lesion PCI. For patients with STEMI, there were no significant mortality differences between patients in SOS and non-SOS hospitals. Patients with STEMI in SOS hospitals had significantly lower 2-year repeat target lesion PCI rates (adjusted hazard ratio, 0.68 [0.49-0.94]). There was no difference in the percentage of patients undergoing PCI in the 2 types of hospitals (75.7% versus 74.6%; P=0.21) or in 30-day mortality of all patients with STEMI (patients who did and did not undergo PCI, 10.86% versus 11.32%; adjusted odds ratio, 1.06 [0.88-1.29]). CONCLUSIONS: Short-term and long-term outcomes were not different in SOS and non-SOS hospitals except that 2-year repeat target lesion PCI rates were lower in SOS hospitals for patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Hannan et al. (2019) conducted a cohort in Coronary Artery Disease and Acute Myocardial Infarction (n=21,924). Treatment in hospitals without on-site surgery (non-SOS) vs. Treatment in hospitals with on-site surgery (SOS) was evaluated on 30-day mortality in patients with STEMI (adjusted OR 1.06, 95% CI 0.88-1.29). Treatment of STEMI patients in hospitals without on-site surgery showed no significant difference in 30-day mortality compared to hospitals with on-site surgery (11.32% vs 10.86%; adjusted OR 1.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: